Levosimendan, a novel myofilament calcium sensitizer, allows weaning of parenteral inotropic therapy in patients with severe congestive heart failure
Autor: | Hosenpud, Jeffrey D. * |
---|---|
Zdroj: | In The American Journal of Cardiology 1999 83(12) Supplement 2:9-11 |
Databáze: | ScienceDirect |
Externí odkaz: |